Physician

Wayne M Cumbria, M.D.

According to 2025 Medicare claims, Wayne Cumbria, M.D. (NPI: 1629048046) practices nephrology in the Lake Havasu City-Kingman, AZ market, with the plurality of this provider's patient population coming from Mohave, AZ. This provider's primary affiliated billing organization is AKDHC, LLC (NPI: 1316902208; TIN: 860959487) and primary practice location at 86403-5681. Cumbria is affiliated with the Mosaic ACO (ACO ID: A5033) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Cumbria's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 623 traditional Medicare patients, billed 5,775 HCPCS/CPT codes, and received $290,338 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,642 prescription claims across 353 beneficiaries totaling $514,303 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 197 claims. Open Payments data shows 32 records totaling $699. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $255,392 and ending at $514,303. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	924	33,456	$418,579
2016	947	28,377	$393,918
2017	898	18,969	$407,189
2018	858	8,613	$376,516
2019	861	8,470	$392,987
2020	815	7,830	$352,374
2021	757	7,264	$356,115
2022	695	7,330	$307,737
2023	633	5,770	$265,215
2024	623	5,775	$290,338

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	256	1,398	$255,392
2016	267	1,789	$426,661
2017	234	1,665	$366,136
2018	243	1,605	$375,530
2019	217	1,153	$360,497
2020	219	1,204	$264,502
2021	242	1,037	$127,581
2022	257	1,029	$195,036
2023	318	1,507	$524,459
2024	353	1,642	$514,303

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	91	$6,048
2016	N/R	246	$12,539
2017	22	359	$15,300
2018	64	527	$25,432
2019	52	502	$15,010
2020	35	357	$9,591
2021	33	326	$7,953
2022	N/R	292	$4,763
2023	N/R	229	$3,439
2024	N/R	197	$2,675

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	89	89	$140
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	269	613	$129
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	89	94	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	280	476	$90
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	125	406	$88

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	277	14,144	$256,630
Velphoro	Sucroferric Oxyhydroxide	28	1,200	$106,687
Veltassa	Patiromer Calcium Sorbitex	29	1,142	$37,693
Rayaldee	Calcifediol	18	600	$23,556
Lanthanum Carbonate	Lanthanum Carbonate	21	630	$14,832

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	40	$971
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	45	$790
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	48	$577
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	33	$314
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	31	$23

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$699	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Wayne M. Cumbria, M.D.?

Tedicare shows public-source Medicare data for Wayne M. Cumbria, M.D. (NPI 1629048046), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wayne M. Cumbria, M.D. have ACO affiliation data?

Wayne M. Cumbria, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Wayne M. Cumbria, M.D.?

Wayne M. Cumbria, M.D. is linked to AKDHC, LLC (billing NPI 1316902208) in the available physician profile data.

Does Wayne M. Cumbria, M.D. have Open Payments data?

Wayne M. Cumbria, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.